Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor
Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating interstitial lung disease characterized by limited therapeutic options, with only two FDA-approved palliative agents currently available. Given its poor prognosis and the high incidence of lung transplantation, there is a pressing...
Saved in:
| Main Authors: | Ilaria Cursaro, Valerio Ciccone, Valeria Tudino, Chiara Papulino, Laura Scalvini, Sandra Donnini, Lucia Morbidelli, Luca Bini, Claudia Landi, Chiara Contri, Silvia Pasquini, Fabrizio Vincenzi, Katia Varani, Alessio Lodola, Marco Mor, Rosaria Benedetti, Lucia Altucci, Stefania Butini, Gabriele Carullo, Sandra Gemma, Giuseppe Campiani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | European Journal of Medicinal Chemistry Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772417425000329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PROTAC Technology as a New Tool for Modern Pharmacotherapy
by: Natalia Kubryń, et al.
Published: (2025-05-01) -
Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer
by: Zhao K, et al.
Published: (2025-06-01) -
Oligonucleotide-based PROTACs to Degrade RNA- and DNA-Binding Proteins
by: Céline N. Weller, et al.
Published: (2025-03-01) -
Modeling PROTAC degradation activity with machine learning
by: Stefano Ribes, et al.
Published: (2024-12-01) -
The Peptide PROTAC Modality: A New Strategy for Drug Discovery
by: Youmin Zhu, et al.
Published: (2025-04-01)